Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | kinesin family member 11 | Starlite/ChEMBL | References |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Treponema pallidum | exodeoxyribonuclease (exoA) | 0.0022 | 0.0132 | 0.5 |
Entamoeba histolytica | kinesin, putative | 0.0032 | 0.056 | 0.4774 |
Mycobacterium ulcerans | exodeoxyribonuclease III protein XthA | 0.0022 | 0.0132 | 0.5 |
Loa Loa (eye worm) | kinesin-like protein KLP2 | 0.0032 | 0.056 | 1 |
Trichomonas vaginalis | ap endonuclease, putative | 0.0022 | 0.0132 | 0.5 |
Toxoplasma gondii | LsmAD domain-containing protein | 0.003 | 0.0466 | 0.7807 |
Entamoeba histolytica | hypothetical protein | 0.0043 | 0.1028 | 1 |
Giardia lamblia | Kinesin-5 | 0.0032 | 0.056 | 1 |
Plasmodium vivax | ataxin-2 like protein, putative | 0.003 | 0.0466 | 0.7807 |
Brugia malayi | hypothetical protein | 0.003 | 0.0466 | 0.4534 |
Echinococcus multilocularis | Basic leucine zipper (bZIP) transcription | 0.0043 | 0.1028 | 0.0908 |
Toxoplasma gondii | kinesin motor domain-containing protein | 0.0032 | 0.056 | 1 |
Plasmodium falciparum | ataxin-2 like protein, putative | 0.003 | 0.0466 | 0.7807 |
Wolbachia endosymbiont of Brugia malayi | exonuclease III | 0.0022 | 0.0132 | 0.5 |
Mycobacterium tuberculosis | Probable exodeoxyribonuclease III protein XthA (exonuclease III) (EXO III) (AP endonuclease VI) | 0.0022 | 0.0132 | 0.5 |
Echinococcus multilocularis | kinesin family 1 | 0.0247 | 1 | 1 |
Schistosoma mansoni | transcription factor LCR-F1 | 0.0043 | 0.1028 | 0.106 |
Brugia malayi | exodeoxyribonuclease III family protein | 0.0022 | 0.0132 | 0.1286 |
Trypanosoma cruzi | PAB1-binding protein , putative | 0.003 | 0.0466 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.003 | 0.0466 | 0.7807 |
Trypanosoma brucei | PAB1-binding protein , putative | 0.003 | 0.0466 | 1 |
Plasmodium falciparum | ataxin-2 like protein, putative | 0.003 | 0.0466 | 0.7807 |
Trichomonas vaginalis | ap endonuclease, putative | 0.0022 | 0.0132 | 0.5 |
Echinococcus granulosus | Basic leucine zipper bZIP transcription | 0.0043 | 0.1028 | 0.0908 |
Leishmania major | hypothetical protein, conserved | 0.003 | 0.0466 | 1 |
Brugia malayi | hypothetical protein | 0.0043 | 0.1028 | 1 |
Plasmodium falciparum | kinesin-5 | 0.0032 | 0.056 | 1 |
Schistosoma mansoni | kinesin eg-5 | 0.0032 | 0.056 | 0.0506 |
Brugia malayi | Kinesin motor domain containing protein | 0.0032 | 0.056 | 0.5446 |
Entamoeba histolytica | hypothetical protein | 0.0043 | 0.1028 | 1 |
Plasmodium vivax | kinesin-5 | 0.0032 | 0.056 | 1 |
Trypanosoma cruzi | PAB1-binding protein , putative | 0.003 | 0.0466 | 1 |
Entamoeba histolytica | hypothetical protein | 0.0043 | 0.1028 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0215 | 0.8591 | 1 |
Entamoeba histolytica | hypothetical protein | 0.0043 | 0.1028 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0043 | 0.1028 | 0.106 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (binding) | = 0.095 uM | Inhibition of C-terminally His6-tagged microtubule-activated KSP motor domain ATPase activity after 15 mins by luciferase-derived luminescence assay | ChEMBL. | 21599002 |
IC50 (binding) | = 0.095 uM | Inhibition of C-terminal His-tagged KSP ATPase motor domain (unknown origin) expressed in bacteria incubated for 30 mins prior to ATP addition measured after 15 mins by luminescence assay | ChEMBL. | 24794744 |
IC50 (functional) | = 1.4 uM | Cytotoxicity against human HeLa cells after 72 hrs by MTS assay | ChEMBL. | 21599002 |
Species name | Source | Reference | Is orphan |
---|---|---|---|
Homo sapiens | ChEMBL23 | 21599002 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
2 literature references were collected for this gene.